Biopharm Services Limited
BioSolve is the biopharmaceutical industry`s most powerful bioprocess analysis tool. BioSolve enables biopharma innovators to reduce manufacturing costs and make informed process decisions to improve profitability and ultimately patient access. Biopharm was founded in December 1998 to develop technology solutions and services for the biopharmaceutical manufacturing business, covering biologic products, facilities and strategy.
Company details
Find locations served, office locations
- Business Type:
- Software vendor
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Internationally (various countries)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
When established, Biopharm Services had two core consultancy services. One is traditional engineering such as P&ID or facility layout, and the second is bespoke economic modelling.
The team have worked with numerous clients to build hundreds of bespoke models.
Our founder Andrew Sinclair’s life-long passion has been to build the software/framework where the user can change process parameters and evaluate the impact on process easily. His vision and VoC which asked for the framework which they can change easily rather than bespoke model matched together. The energy led the team to build the first version of our software – BioSolve Process. Since its launch in 2008, it has been loved and used in our industry. It grew up with the clients. With their love and voices, it has been growing to include more functionalities and capabilities.
Thanks to our user community’s support, BioSolve Process became the biopharmaceutical industry’s most powerful set of bioprocess analysis tools. The BioSolve product range enables biopharma innovators to reduce manufacturing costs and make informed process decisions to improve profitability and ultimately patient access.
Saving our clients millions every year, BioSolve products provide standardised, impartial and industry-wide information across organisations, helping biopharma companies rationalise and de-risk their business decision-making.
Unlike in-house systems, BioSolve Process accesses information from across the biopharmaceutical sector to deliver impartial knowledge and advantage.